Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

J Fernando Arevalo, AAO 2021: Retinal and Choroidal Manifestations of Selected Systemic Diseases

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Feb 3rd 2022

It was great to catch up with our valued Editorial Board member, J Fernando Arevalo (Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA), who gave us an overview of his course at the American Academy of Ophthalmology Virtual Meeting 2021 on retinal and choroidal manifestations of selected systemic diseases.

Questions

  1. Could you give us a brief overview of the topics covered by your latest book on retinal and choroidal manifestations of systemic diseases? (00:36)
  2. What are the most common retinal and choroidal manifestations of COVID-19? (03:09)

Speaker Disclosure: J Fernando Arevalo has received consultant and advisor fees from Abbvie, Genentech and Thea Laboratories, patents/royalty from Springer SBM LLC, and grant support from Topcon Medical Systems Inc.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.

Filmed in coverage of AAO 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup